A Compassionate Use Program to Provide Access to Sodium Thiosulfate

Condition:   Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma Intervention:   Drug: Sodium Thiosulfate (STS) Sponsors:   TRPHARM;   Fennec Pharma;   Klinar CRO Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials